Matthew Kaplan
Stock Analyst at Ladenburg Thalmann
(3.29)
# 1,032
Out of 4,761 analysts
27
Total ratings
62.5%
Success rate
12.12%
Average return
Main Sectors:
Stocks Rated by Matthew Kaplan
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| EYEN Eyenovia | Downgrades: Neutral | n/a | $1.68 | - | 1 | Nov 18, 2024 | |
| UTHR United Therapeutics | Maintains: Buy | $319 → $344 | $361.10 | -4.74% | 9 | Oct 31, 2024 | |
| URGN UroGen Pharma | Maintains: Buy | $48 → $54 | $10.08 | +430.75% | 1 | Jun 14, 2024 | |
| TGTX TG Therapeutics | Maintains: Buy | $39 → $40 | $30.88 | +29.53% | 3 | May 2, 2024 | |
| LQDA Liquidia | Maintains: Buy | $15 → $30 | $16.12 | +86.16% | 2 | Dec 21, 2023 | |
| ARDX Ardelyx | Maintains: Buy | $7.5 → $8.5 | $5.06 | +67.98% | 4 | Aug 3, 2023 | |
| AVDL Avadel Pharmaceuticals | Maintains: Buy | $15 → $16 | $8.41 | +90.25% | 1 | May 2, 2023 | |
| KPRX Kiora Pharmaceuticals | Reiterates: Buy | $1,071 | $3.47 | +30,764.55% | 2 | Feb 8, 2023 | |
| XAIR Beyond Air | Maintains: Buy | $17 → $23 | $0.35 | +6,465.80% | 1 | Jun 29, 2022 | |
| LPCN Lipocine | Upgrades: Buy | $51 | $3.38 | +1,408.88% | 1 | Dec 10, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $16 | $8.00 | +100.00% | 1 | Oct 14, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $45 | $3.72 | +1,109.68% | 1 | Jan 22, 2020 |
Eyenovia
Nov 18, 2024
Downgrades: Neutral
Price Target: n/a
Current: $1.68
Upside: -
United Therapeutics
Oct 31, 2024
Maintains: Buy
Price Target: $319 → $344
Current: $361.10
Upside: -4.74%
UroGen Pharma
Jun 14, 2024
Maintains: Buy
Price Target: $48 → $54
Current: $10.08
Upside: +430.75%
TG Therapeutics
May 2, 2024
Maintains: Buy
Price Target: $39 → $40
Current: $30.88
Upside: +29.53%
Liquidia
Dec 21, 2023
Maintains: Buy
Price Target: $15 → $30
Current: $16.12
Upside: +86.16%
Ardelyx
Aug 3, 2023
Maintains: Buy
Price Target: $7.5 → $8.5
Current: $5.06
Upside: +67.98%
Avadel Pharmaceuticals
May 2, 2023
Maintains: Buy
Price Target: $15 → $16
Current: $8.41
Upside: +90.25%
Kiora Pharmaceuticals
Feb 8, 2023
Reiterates: Buy
Price Target: $1,071
Current: $3.47
Upside: +30,764.55%
Beyond Air
Jun 29, 2022
Maintains: Buy
Price Target: $17 → $23
Current: $0.35
Upside: +6,465.80%
Lipocine
Dec 10, 2020
Upgrades: Buy
Price Target: $51
Current: $3.38
Upside: +1,408.88%
Oct 14, 2020
Initiates: Buy
Price Target: $16
Current: $8.00
Upside: +100.00%
Jan 22, 2020
Initiates: Buy
Price Target: $45
Current: $3.72
Upside: +1,109.68%